These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9121090)

  • 1. [Neoton (exogenic phosphocreatinine) in combined therapy of chronic cardiac failure].
    Nedoshivin AO; Perepech NB
    Klin Med (Mosk); 1996; 74(9):45-8. PubMed ID: 9121090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova A'E
    Klin Med (Mosk); 1997; 75(10):52-4. PubMed ID: 9490342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoton and thrombolytic therapy of myocardial infarction].
    Perepech NB; Nedoshivin AO; Nesterova IV
    Ter Arkh; 2001; 73(9):50-5. PubMed ID: 11642083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Essential phospholipids in combined therapy of chronic circulatory insufficiency].
    Golochevskaia VS; Baranskaia EK; Trofimenko IV; Balakhonova NP; Burmakin IA; Kop'ev VI; Zadorozhnaia OO
    Klin Med (Mosk); 1997; 75(5):30-3. PubMed ID: 9235405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova AE
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential therapy of chronic heart failure].
    Riegger AJ
    Internist (Berl); 1993 Oct; 34(10):939-43. PubMed ID: 8225843
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physical rehabilitation in the complex hospital therapy of patients with chronic low cardiac output].
    Efremushkin GG; Antropova ON; Osipova IV
    Ter Arkh; 2003; 75(12):50-4. PubMed ID: 14959471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI
    Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of heart failure. II. Therapy of chronic heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):36-8, 41-5. PubMed ID: 9280747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atenolol as add-on therapy to fosinopril in heart failure.
    Pacher R; Hülsmann M; Berger R; Koller-Strametz J; Kos T; Frey B; Dukat A; Stanek B
    Wien Klin Wochenschr; 1997 Apr; 109(7):232-8. PubMed ID: 9141231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
    Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.